See also this year's filing and all EDGAR filings for this company.
PDF Report 0001094038_2024_Marker_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001094038, Marker Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 17,127,391 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 3,074,848 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,067,503 |
| 9 | ResearchAndDevelopmentExpense | 18,092,855 |
| 10 | remainder_Expenses | 3,675 |
| 11 | remainder_Revenues | 5,744,754 |
| 12 | remainder_NetIncome | 26,483 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 17,127,391 |
| 1 | Liabilities | 3,074,848 |
| 2 | Expenses | 27,164,033 |
| 3 | Revenues | 5,744,754 |
| 4 | StockholdersEquity | 14,052,543 |
| 5 | NetIncome | -21,392,796 |
| 6 | ComprehensiveNetIncome | -21,392,796 |
| 7 | BaseVar | 26,568,754 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.915 |
| 9 | EconomicCapitalRatio | 2.23 |
Edgar->Model Mapping
Feature Distribution
Change over Time
